3L3 Stock Overview
A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Tactile Systems Technology, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.80 |
| 52 Week High | US$20.00 |
| 52 Week Low | US$10.10 |
| Beta | 1.24 |
| 1 Month Change | -25.32% |
| 3 Month Change | -28.92% |
| 1 Year Change | -21.85% |
| 3 Year Change | -31.79% |
| 5 Year Change | -59.03% |
| Change since IPO | -52.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3L3 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -7.8% | 1.4% | 0.5% |
| 1Y | -21.9% | -10.7% | 15.4% |
Return vs Industry: 3L3 underperformed the German Medical Equipment industry which returned -11.2% over the past year.
Return vs Market: 3L3 underperformed the German Market which returned 15.5% over the past year.
Price Volatility
| 3L3 volatility | |
|---|---|
| 3L3 Average Weekly Movement | 6.4% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in DE Market | 12.0% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: 3L3 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 3L3's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 1,037 | Sheri Dodd | tactilemedical.com |
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
Tactile Systems Technology, Inc. Fundamentals Summary
| 3L3 fundamental statistics | |
|---|---|
| Market cap | €285.21m |
| Earnings (TTM) | €15.58m |
| Revenue (TTM) | €269.22m |
18.3x
P/E Ratio1.1x
P/S RatioIs 3L3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3L3 income statement (TTM) | |
|---|---|
| Revenue | US$292.98m |
| Cost of Revenue | US$76.30m |
| Gross Profit | US$216.69m |
| Other Expenses | US$199.73m |
| Earnings | US$16.96m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.72 |
| Gross Margin | 73.96% |
| Net Profit Margin | 5.79% |
| Debt/Equity Ratio | 12.1% |
How did 3L3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/17 09:47 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tactile Systems Technology, Inc. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Kyle Bauser | B. Riley Securities, Inc. |
| Michael Gorman | BTIG |